Chinese astragalus

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• allergic rhinitis [Insufficient Evidence]
• amenorrhea [Insufficient Evidence]
• anemia, chemo-related [Insufficient Evidence]
• angina [Insufficient Evidence]
• anthracycline-induced cardiotoxicity [Insufficient Evidence]
• aplastic anemia [Insufficient Evidence]
• asthma [Insufficient Evidence]
• beta-thalassemia [Insufficient Evidence]
• breast CA [Insufficient Evidence]
• cervical CA [Insufficient Evidence]
• CHF [Insufficient Evidence]
• chronic fatigue syndrome [Insufficient Evidence]
• cirrhosis [Insufficient Evidence]
• CKD [Insufficient Evidence]
• colorectal CA [Insufficient Evidence]
• diabetes mellitus, type 2 [Insufficient Evidence]
• diabetic nephropathy [Insufficient Evidence]
• diabetic retinopathy [Insufficient Evidence]
• diarrhea, chemo-related [Insufficient Evidence]
• fatigue, chemo-related [Insufficient Evidence]
• fibromyalgia [Insufficient Evidence]
• gastric CA [Insufficient Evidence]
• hearing loss [Insufficient Evidence]
• hepatitis B [Insufficient Evidence]
• HIV/AIDS [Insufficient Evidence]
• leukopenia, chemo-related [Insufficient Evidence]
• IgA nephropathy [Insufficient Evidence]
• lung CA [Insufficient Evidence]
• membranous nephropathy [Insufficient Evidence]
• menopausal sx [Insufficient Evidence]
• MI [Insufficient Evidence]
• myocarditis [Insufficient Evidence]
• nausea/vomiting, chemo-related [Insufficient Evidence]
• nephrotoxicity, chemo-related [Insufficient Evidence]
• nephrotic syndrome [Insufficient Evidence]
• obesity [Insufficient Evidence]
• post-stroke fatigue [Insufficient Evidence]
• SLE [Insufficient Evidence]
• tinnitus [Insufficient Evidence]
• URI [Insufficient Evidence]
• UTI [Insufficient Evidence]
• wound healing [Insufficient Evidence]